From GlobeNewswire: 2025-05-29 10:00:00

The global Ureteroscope Market was USD 1.33 billion in 2024, expected to reach USD 2.09 billion by 2032 with a 5.86% CAGR. Growth is driven by urological conditions like kidney stones, improved imaging devices, and demand for minimally invasive treatments.

In the US, the market was USD 0.38 billion in 2024, set to grow at a 5.4% CAGR due to high kidney stone surgeries and advanced technologies. Flexible ureteroscopes held 58% market share in 2024, with semi-flexible ones growing rapidly.

North America dominated the market in 2024, while Asia Pacific is expected to grow the fastest by 2032. Urolithiasis accounted for 64% of the market share in 2024, with hospitals holding 61% market share.

Recent developments include the launch of the NAVIUS system for optimized procedures and FDA clearance for Olympus’ RenaFlex Single-Use Flexible Ureteroscope. Urolithiasis affects 12% of men and 6% of women globally, with over 800,000 ureteroscopy procedures in North America in 2023.



Read more at GlobeNewswire: Ureteroscope Market to Hit USD 2.09 Billion by 2032, Driven